Kazia Therapeutics
IPOKazia Therapeutics, ASX: KZA, biotechnology
Public · Sydney, Australia · Founded 2016
- Headquarters
- Sydney
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- kaziatx.com
- Type
- Public
About
Kazia Therapeutics is an Australian oncology company developing innovative cancer drugs, with its lead program paxalisib targeting brain tumors.
Summary
Kazia Therapeutics is a Biotech company based in Sydney, Australia, founded in 2016.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kazia-therapeutics"><img src="https://indexed.vc/api/badge/company/kazia-therapeutics" alt="Kazia Therapeutics on Indexed.vc" width="260" height="76" /></a>